Veronica Wallin

Veronica Wallin

Director of Finance/CFO at 4C GROUP AB
40 year
Health Technology
Consumer Services
Distribution Services

Profile

Veronica Wallin is Chief Executive Officer at AB P.J.
Haegerstrand since 2016.
Independent Director at IRLAB Therapeutics AB since 2023.
Director at Bostadsrattsforeningen Kettingen 1, Episurf De GmbH, Episurf Uk Ltd., Episurf Australia Pty Ltd., and Episurf India Pvt Ltd. Chief Financial Officer at 4C Group AB starting in 2025.
Former Independent Director at Alligator Bioscience AB from 2021 to 2024.
Director at Episurf Operations AB, Episurf IP-Management AB, and Episurf Europe AB. Chief Financial Officer at Episurf Medical AB from 2017 to 2025.
Chief Financial Officer at ApoEx AB from 2013 to 2016.
Auditor at Bdo Stockholm AB from 2011 to 2013.
Education includes a graduate degree from the University of Stockholm.

Veronica Wallin active positions

CompaniesPositionStart
IRLAB THERAPEUTICS AB Director/Board Member 01/01/2023
4C GROUP AB Director of Finance/CFO 01/06/2025
Bostadsrattsforeningen Kettingen 1
Director/Board Member -
Chief Executive Officer 01/01/2016

Former positions of Veronica Wallin

CompaniesPositionEnd
EPISURF MEDICAL AB Director of Finance/CFO 19/05/2025
ALLIGATOR BIOSCIENCE AB Director/Board Member 07/05/2024
Director of Finance/CFO 01/01/2016
Bdo Stockholm AB
Comptroller/Controller/Auditor 01/05/2013
See the detail of Veronica Wallin's experience

Training of Veronica Wallin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

18

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Consumer Services

Health Technology

Bdo Stockholm AB

Distribution Services

Commercial Services

Health Technology

Health Technology

Episurf IP-Management AB

Bostadsrattsforeningen Kettingen 1

Transportation

  1. Stock Market
  2. Insiders
  3. Veronica Wallin